Li J - Search Results

1

Protective effect of inhibiting necroptosis on gentamicin-induced nephrotoxicity.

Hu BF, Gong Q, Chen SQ, Yue L, Ma WX, Wang F, Feng XW, Wang JN, Li C, Liu MM, Wang XF, Meng XM, Li J, Wen JG. Hu BF, et al. Among authors: li c, li j. FASEB J. 2022 Sep;36(9):e22487. doi: 10.1096/fj.202200163R. FASEB J. 2022. PMID: 35947125

2

EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis.

Yang Y, Chen XX, Li WX, Wu XQ, Huang C, Xie J, Zhao YX, Meng XM, Li J. Yang Y, et al. Among authors: li j, li wx. J Cell Mol Med. 2017 Oct;21(10):2317-2328. doi: 10.1111/jcmm.13153. Epub 2017 Mar 23. J Cell Mol Med. 2017. PMID: 28332284 Free PMC article.

3

Noncoding RNAs in acute kidney injury.

Ren GL, Zhu J, Li J, Meng XM. Ren GL, et al. Among authors: li j. J Cell Physiol. 2019 Mar;234(3):2266-2276. doi: 10.1002/jcp.27203. Epub 2018 Aug 26. J Cell Physiol. 2019. PMID: 30146769 Review.

4

Noncoding RNAs in alcoholic liver disease.

Li HD, Du XS, Huang HM, Chen X, Yang Y, Huang C, Meng XM, Li J. Li HD, et al. Among authors: li j. J Cell Physiol. 2019 Sep;234(9):14709-14720. doi: 10.1002/jcp.28229. Epub 2019 Jan 31. J Cell Physiol. 2019. PMID: 30701547 Review.

5

PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/β-catenin signalling pathway.

Chen Y, Chen X, Ji YR, Zhu S, Bu FT, Du XS, Meng XM, Huang C, Li J. Chen Y, et al. Among authors: li j. J Cell Mol Med. 2020 Jul;24(13):7405-7416. doi: 10.1111/jcmm.15356. Epub 2020 May 28. J Cell Mol Med. 2020. PMID: 32463161 Free PMC article.

6

MicroRNA-708 modulates Hepatic Stellate Cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88.

Xu T, Pan L, Li L, Hu S, Zhou H, Yang C, Yang J, Li H, Liu Y, Meng X, Li J. Xu T, et al. Among authors: li j, li h, li l. J Cell Mol Med. 2020 Jul;24(13):7127-7140. doi: 10.1111/jcmm.15119. Epub 2020 May 28. J Cell Mol Med. 2020. PMID: 32463570 Free PMC article.

7

LncRNA NEAT1: Shedding light on mechanisms and opportunities in liver diseases.

Bu FT, Wang A, Zhu Y, You HM, Zhang YF, Meng XM, Huang C, Li J. Bu FT, et al. Among authors: li j. Liver Int. 2020 Nov;40(11):2612-2626. doi: 10.1111/liv.14629. Epub 2020 Oct 13. Liver Int. 2020. PMID: 32745314 Review.

8

Arrb2 causes hepatic lipid metabolism disorder via AMPK pathway based on metabolomics in alcoholic fatty liver.

Sun YY, Wu DQ, Yin NN, Yang L, Chen X, Li HD, Li XF, Huang C, Meng XM, Wang H, Li J. Sun YY, et al. Among authors: li xf, li j, li hd. Clin Sci (Lond). 2021 May 28;135(10):1213-1232. doi: 10.1042/CS20201363. Clin Sci (Lond). 2021. PMID: 33871024

9

The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics.

You H, Wang L, Bu F, Meng H, Pan X, Li J, Zhang Y, Wang A, Yin N, Huang C, Li J. You H, et al. Among authors: li j. FASEB J. 2021 Jul;35(7):e21700. doi: 10.1096/fj.202002319RRR. FASEB J. 2021. PMID: 34105828

10

Advancements in the Alcohol-Associated Liver Disease Model.

Zhu L, Li HD, Xu JJ, Li JJ, Cheng M, Meng XM, Huang C, Li J. Zhu L, et al. Among authors: li jj, li j, li hd. Biomolecules. 2022 Jul 27;12(8):1035. doi: 10.3390/biom12081035. Biomolecules. 2022. PMID: 36008929 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

178,944 results

Search Page